TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA)
Last updated:
Abstract:
Compositions and methods are described for the delivery of a fully human-glycosylated (HuGly) .alpha.-L-iduronidase (ID-UA) to the cerebrospinal fluid of the central nervous system (CNS) of a human subject diagnosed with mucopolysaccharidosis I (MPS I).
Status:
Application
Type:
Utility
Filling date:
17 Jul 2019
Issue date:
9 Sep 2021